Sign in

CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

BridgeBio Oncology Therapeutics, Inc.

Sign in to watch
Ticker
BBOT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857 702 0377
Business address
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
Former names
Helix Acquisition Corp. II
  1. EFFECT Other Notice of Effectiveness
  2. EFFECT Other Notice of Effectiveness
  3. POS AM Other Post-effective Amendment for Registration Statement
  4. EFFECT Other Notice of Effectiveness
  5. POS AM Other Post-effective Amendment for Registration Statement
  6. ARS Other Annual Report to Security Holders
  7. DEFA14A Proxy Proxy Materials
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. EFFECT Other Notice of Effectiveness
  11. EFFECT Other Notice of Effectiveness
  12. POS AM Other Post-effective Amendment for Registration Statement
  13. EFFECT Other Notice of Effectiveness
  14. DRSLTR Other Correspondence Related to Draft Registration Statement
  15. DRS/A Other Draft Registration Statement
  16. DRS Other Draft Registration Statement
  17. DRSLTR Other Correspondence Related to Draft Registration Statement
  18. EFFECT Other Notice of Effectiveness
  19. S-1MEF Other S-1MEF
  20. CERT Other Certification

Page 1 of 2 · 22 filings